| Honora E Kennedy, MD | |
|
9801 Dupont Ave S Ste 200, Bloomington, MN 55431-3200 | |
| (952) 888-5800 | |
| (952) 567-6156 |
| Full Name | Honora E Kennedy |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 9801 Dupont Ave S Ste 200, Bloomington, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063474906 | NPI | - | NPPES |
| 829398800 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 31464 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Honora E Kennedy, MD 9801 Dupont Ave S Ste 425, Bloomington, MN 55431-3873 Ph: (952) 888-5800 | Honora E Kennedy, MD 9801 Dupont Ave S Ste 200, Bloomington, MN 55431-3200 Ph: (952) 888-5800 |
News Archive
News outlets set the scene for some of the tough health policy questions the two presidential candidates might face during tomorrow night's debate. And new ads about the health law and women's health issues have been unleashed.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, today provided an update on its Phase 2 clinical trial for the use of its lead compound, NVC-422, to prevent urinary catheter blockage and encrustation which is often a contributing factor to urinary tract infections in chronically catheterized patients.
John Wiley & Sons, Inc., The Physiological Society (TPS), and The American Physiological Society (APS) announced today their partnership to publish the new open access peer-reviewed journal, Physiological Reports, which will launch early next year.
Researchers investigating the drug prescription response to a "superbug" enzyme that renders bacteria resistant to antibiotics are available to discuss why such resistance is posing a growing risk during pandemics such as the current coronavirus.
Vaxil Bio, a leading developer of immunotherapeutic products to treat cancer and infectious diseases, reports today that its lead drug candidate, ImMucin has received orphan drug designation from the European Medicines Agency of the European Commission for the treatment of Multiple Myeloma (MM), a blood cancer.
› Verified 6 days ago
Mehdi Roozbahani, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 9801 Dupont Ave S Ste 110, Bloomington, MN 55431 Phone: 612-355-6510 Fax: 612-713-9360 | |
Kaihan Fakhar, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8600 Nicollet Ave S, Bloomington, MN 55420 Phone: 952-541-2800 Fax: 952-886-7015 | |
Elizabeth A Davis, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9801 Dupont Ave S, Suite 200, Bloomington, MN 55431 Phone: 952-888-5800 Fax: 952-884-2656 | |
Jefferson Berryman, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9801 Dupont Ave S Ste 200, Bloomington, MN 55431 Phone: 952-888-5800 Fax: 952-567-6156 | |
Jill Suzanne Melicher Larson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9801 Dupont Ave S, 200, Bloomington, MN 55431 Phone: 952-888-5800 | |
Thomas Lang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7920 Old Cedar Ave S, Bloomington, MN 55425 Phone: 952-428-1800 |